Kestra Private Wealth Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.88M | Buy |
14,490
+1,833
| +14% | +$743K | 0.08% | 251 |
|
|
2025
Q1 | $6.3M | Buy |
12,657
+743
| +6% | +$370K | 0.11% | 218 |
|
|
2024
Q4 | $6.2M | Buy |
11,914
+1,118
| +10% | +$582K | 0.11% | 208 |
|
|
2024
Q3 | $6.68M | Sell |
10,796
-702
| -6% | -$434K | 0.12% | 185 |
|
|
2024
Q2 | $6.36M | Buy |
11,498
+509
| +5% | +$281K | 0.13% | 180 |
|
|
2024
Q1 | $6.39M | Buy |
10,989
+977
| +10% | +$568K | 0.14% | 167 |
|
|
2023
Q4 | $5.31M | Buy |
10,012
+1,288
| +15% | +$684K | 0.14% | 184 |
|
|
2023
Q3 | $4.42M | Buy |
8,724
+2,658
| +44% | +$1.35M | 0.14% | 172 |
|
|
2023
Q2 | $3.16M | Buy |
6,066
+1,293
| +27% | +$675K | 0.11% | 213 |
|
|
2023
Q1 | $2.75M | Buy |
4,773
+203
| +4% | +$117K | 0.11% | 204 |
|
|
2022
Q4 | $2.52M | Buy |
4,570
+172
| +4% | +$94.7K | 0.13% | 186 |
|
|
2022
Q3 | $2.23M | Buy |
4,398
+216
| +5% | +$110K | 0.13% | 182 |
|
|
2022
Q2 | $2.27M | Buy |
4,182
+36
| +0.9% | +$19.6K | 0.13% | 186 |
|
|
2022
Q1 | $2.45M | Sell |
4,146
-508
| -11% | -$300K | 0.12% | 186 |
|
|
2021
Q4 | $3.11M | Buy |
4,654
+1,510
| +48% | +$1.01M | 0.15% | 152 |
|
|
2021
Q3 | $1.8M | Sell |
3,144
-1,201
| -28% | -$686K | 0.1% | 225 |
|
|
2021
Q2 | $2.19M | Sell |
4,345
-34
| -0.8% | -$17.2K | 0.13% | 169 |
|
|
2021
Q1 | $2M | Buy |
4,379
+153
| +4% | +$69.8K | 0.14% | 172 |
|
|
2020
Q4 | $1.95M | Buy |
4,226
+1,933
| +84% | +$892K | 0.14% | 166 |
|
|
2020
Q3 | $1.01M | Buy |
+2,293
| New | +$1.01M | 0.09% | 234 |
|